Home

Norma Ann Provencio

CIK 1343811 · last filed 2025-11-18

Norma Ann Provencio is a corporate insider who has filed 102 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for BZH, was dated Nov 18, 2025. Across all open-market trades the lifetime net is +$236.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.9M across reported positions. 45 SEC filings were submitted jointly with Bausch Health Companies Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.86M

Companies

2

Total Filings

102

Lifetime Open-Market Net

$236.0K

Filer Profile

Reported Address
2002 SUMMIT BLVD NE
15TH FLOOR
ATLANTA, GA 30319
Related Filers
Bausch Health Companies Inc. — 45 joint filings, latest 2016-05-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BZH Director 115,988 $33.26 $3.86M $158.4K 17 2025-11-18
VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted Director 2,500 — — $77.6K 39 2010-09-30

Recent Filings

102 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-11-18 BZH Grant (A) +7,199 $0 EDGAR
2025-02-10 BZH Buy (P) +5,000 $109.7K EDGAR
2024-11-19 BZH Grant (A) +5,051 $0 EDGAR
2023-11-21 BZH Grant (A) +6,024 $0 EDGAR
2022-11-16 BZH Grant (A) +14,181 $0 EDGAR
2021-11-16 BZH Grant (A) +7,679 $0 EDGAR
2020-11-18 BZH Grant (A) +9,177 $0 EDGAR
2019-11-19 BZH Grant (A) +8,002 $0 EDGAR
2018-11-19 BZH Grant (A) +10,183 $0 EDGAR
2017-11-17 BZH Grant (A) +4,887 $0 EDGAR
Showing 1–10 of 102
Page 1 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.